Greater Hartford companies held their own in Connecticut’s strongest third-quarter venture capital showing since 2014.
Greater Hartford companies held their own in Connecticut's strongest third-quarter venture capital showing since 2014.
During the three months ended Sept. 30, 10 Connecticut companies secured a combined $82.1 million in funding, according to the latest PwC/CB Insights MoneyTree Report. That was up from $13.3 million raised by nine companies in the same quarter last year.
Area companies on the list of top deals in the third quarter included Farmington's Bioarray Genetics, which is developing a diagnostic test to detect breast cancer ($5.2 million); Manchester's Woven Orthopedic Technologies, which makes gripping sleeves for orthopedic bone screws ($4.2 million); and West Hartford's ReadyDock, which makes disinfecting stations for cell phones in healthcare and other settings ($1.9 million).
The largest Connecticut deal was $50.5 million raised by New Haven biotech Trevi Therapeutics, which is developing a treatment for a skin condition called pruritis.
Through the first three quarters of the year, Connecticut companies raised $176.7 million vs. $107.3 million raised during the same time period in 2016.
